Table 4 Summary of DCs determined by EAMSD or JD analysis (independent fitting)

ribDG-mV

0.657 (0.994)

0.234 ± 0.002 (7.9%)

1.16 ± 0.001 (92.1%)

–

144 (49)

44 (5860)

0.092 (6.7)

2.86

ribDG-mV (ΔribH)

0.682 (0.994)

0.162 ± 0.001 (7.69%)

1.14 ± 0.001 (92.3%)

126 (44)

52 (5918)

0.1 (7.4)

2.87

ribAB-mV

0.646 (0.992)

0.0966 ± 0.001 (2.6%)

1.17 ± 0 (97.4%)

–

179 (55)

49 (8161)

0.1 (7.3)

2.74

ribAB-mV (ΔribH)

0.553 (0.994)

1.02 ± 0 (100%)

–

–

65 (19)

115 (7262)

0.11 (8)

2.82

ribE-mV

0.570 (0.994)

0.0287 ± 0.001 (1.3%)

0.514 ± 0.008 (14%)

1.12 ± 0.002 (84.7%)

94 (36)

70 (5943)

0.11 (7.7)

2.69

ribE-mV (ΔribH)

0.691 (0.994)

1.3 ± 0 (100 %)

–

–

316 (121)

19 (5868)

0.091 (6.6)

2.75

ribH-mV

0.352 (0.997)

0.0815 ± 0 (10%)

0.375 ± 0 (65%)

1.01 ± 0.001 (25%)

76 (25)

143 (10,679)

0.14 (10)

2.80

ribH-mV (ΔribE, incl. outliers)

0.203 (0.989)

0.0164 ± 0 (16%)

0.168 ± 0 (37%)

0.684 ± 0.001 (47%)

80 (27)

133 (10,637)

0.17 (13)

2.81

ribH-mV (ΔribE, excl. outliers)

0.237 (0.993)

0.0319 ± 0 (9.1%)

0.18 ± 0 (40%)

0.691 ± 0.001 (50.9%)

79 (27)

134 (10,622)

0.16 (11)

2.82

ribH-mV (control)

0.329 (0.997)

0.0855 ± 0 (11.3%)

0.37 ± 0 (66.1%)

1.04 ± 0.001 (22.6%)

239 (83)

148 (33,386)

0.14 (10)

2.86

ribH-mV (30 min Rifampicin)

0.463 (0.997)

0.0665 ± 0 (3.79%)

0.475 ± 0 (64.2%)

1.11 ± 0.001 (32.01%)

227 (78)

161 (34,352)

0.13 (9.7)

2.73

ribAB-mV (ectopic)

0.653 (0.994)

1.13 ± 0.001 (94.4%)

0.343 ± 0.004 (5.65%)

–

201 (60)

51 (10,342)

0.12 (7.4)

2.70

ribAB-mV (ectopic, ΔribH)

0.532 (0.995)

0.913 ± 0 (100%)

–

–

65 (27)

172 (11,186)

0.1 (8.5)

2.70

ribE-mV (ectopic)

0.589 (0.995)

1.1 ± 0.002 (98.8% ± 0.004)

0.539 ± 0.067 (98.8% ± 0.004)

-

95 (30)

126 (10,690)

0.11 (7.8)

2.90

ribE-mV (ectopic, ΔribH)

0.556 (0.995)

1.08 ± 0 (100%)

63 (31)

178 (10,265)

0.11 (7.8)

2.88

ribE-mV (ectopic, ΔribE)

0.514 (0.994)

0.917 ± 0 (100%)

111 (45)

102 (10,612)

0.11 (8.2)

2.69